These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34093531)

  • 1. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.
    Doerflinger M; Haeusler GM; Li-Wai-Suen CSN; Clark JE; Slavin M; Babl FE; Allaway Z; Mechinaud F; Smyth GK; De Abreu Lourenco R; Phillips B; Pellegrini M; Thursky KA
    Front Immunol; 2021; 12():641879. PubMed ID: 34093531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.
    Kitanovski L; Jazbec J; Hojker S; Derganc M
    Support Care Cancer; 2014 Jan; 22(1):269-77. PubMed ID: 24057110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
    Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
    Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of serum endothelial adhesion molecules in pediatric patients with leukemia with febrile neutropenia to predict bacteremia.
    Arıkan K; Karadağ-Oncel E; Aytac S; Cengiz AB; Duygu Cetinkaya F; Kara A; Ceyhan M
    Cytokine; 2021 Dec; 148():155692. PubMed ID: 34500368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procalcitonin for early diagnosis of bacteraemia in children with cancer].
    Chawes BL; Rechnitzer C; Schmiegelow K; Tvede M
    Ugeskr Laeger; 2007 Jan; 169(2):138-42. PubMed ID: 17227662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
    Srinivasan A; Kumar N; Scott JX
    Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.
    García de Guadiana-Romualdo L; Jiménez-Santos E; Cerezuela-Fuentes P; Español-Morales I; Berger M; Esteban-Torrella P; Hernando-Holgado A; Albaladejo-Otón MD
    Clin Chem Lab Med; 2019 Mar; 57(4):540-548. PubMed ID: 30240355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
    van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
    Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
    Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
    Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study.
    Zheng H; Luo Z; Yi Y; Liu K; Huo Z; You Y; Li H; Tang M
    Cancer Med; 2024 Jul; 13(13):e7307. PubMed ID: 38967137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Presepsin, Procalcitonin, Interleukin-8 and C-Reactive Protein in Predicting Bacteraemia in Febrile Neutropenic Adult Patients with Haematological Malignancies.
    Kostic I; Gurrieri C; Piva E; Semenzato G; Plebani M; Caputo I; Vianello F
    Mediterr J Hematol Infect Dis; 2019; 11(1):e2019047. PubMed ID: 31528313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
    Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
    Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment and management of fever during neutropenia in children with cancer.
    Arif T; Phillips RS
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27887. PubMed ID: 31250539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of bacteraemia in low-risk patients with febrile neutropenia.
    Ahn S; Lee YS; Chun YH; Lim KS; Kim W; Lee JL
    Emerg Med J; 2012 Sep; 29(9):715-9. PubMed ID: 22011971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score.
    Chaftari P; Chaftari AM; Hachem R; Yeung SJ; Dagher H; Jiang Y; Malek AE; Dailey Garnes N; Mulanovich VE; Raad I
    Cancer Med; 2021 Dec; 10(23):8475-8482. PubMed ID: 34725958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.
    Ahn S; Lee YS; Lim KS; Lee JL
    Support Care Cancer; 2013 Aug; 21(8):2303-8. PubMed ID: 23519568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department.
    García de Guadiana-Romualdo L; Cerezuela-Fuentes P; Español-Morales I; Esteban-Torrella P; Jiménez-Santos E; Hernando-Holgado A; Albaladejo-Otón MD
    Biochem Med (Zagreb); 2019 Feb; 29(1):010702. PubMed ID: 30591812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream Infections in Febrile Neutropenic Pediatric Cancer Patients: Microbiological and Sepsis Biomarkers Insight.
    Daef EA; Elsherbiny NM; Agban MN; Riad KF; Mohammed LF
    Egypt J Immunol; 2018 Jun; 25(2):21-34. PubMed ID: 30600945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.